Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.

Nominally significant improvements in the change from baseline in morning pre-dose trough FEV 1 over Weeks 12–24 were observed for BGF MDI vs GFF MDI (least squares mean [LSM] difference 37 mL, 95% confidence interval [CI] 3, 72; P =0.0337) and BFF MDI (67 mL; 95% CI 25, 109; P =0.0020).

also in 7,732 other papers